Schonfeld Strategic Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,498
Closed -$152K 2081
2023
Q4
$152K Buy
+5,498
New +$335K ﹤0.01% 1574
2022
Q4
Sell
-3,782
Closed -$480K 2608
2022
Q3
$480K Buy
3,782
+3,047
+415% +$345K ﹤0.01% 1786
2022
Q2
$61K Sell
735
-9,500
-93% -$737K ﹤0.01% 2198
2022
Q1
$993K Buy
10,235
+9,680
+1,744% +$1.28M 0.01% 996
2021
Q4
$111K Buy
+555
New +$131K ﹤0.01% 1865
2021
Q3
Sell
-1,668
Closed -$691K 2169
2021
Q2
$691K Buy
1,668
+1,120
+204% +$444K 0.01% 1050
2021
Q1
$214K Buy
+548
New +$270K ﹤0.01% 1471
2020
Q4
Sell
-511
Closed -$357K 1583
2020
Q3
$357K Buy
+511
New +$399K 0.01% 1029
2020
Q2
Sell
-545
Closed -$324K 1247
2020
Q1
$324K Sell
545
-621
-53% -$605K 0.02% 730
2019
Q4
$1.33M Buy
+1,166
New +$1.27M 0.03% 431
2018
Q3
Sell
-1,004
Closed -$2.04M 807
2018
Q2
$2.04M Buy
+1,004
New +$2.29M 0.11% 263
2016
Q3
Sell
-2,224
Closed -$1.25M 420
2016
Q2
$1.25M Buy
2,224
+1,553
+231% +$880K 0.28% 105
2016
Q1
$370K Buy
+671
New +$412K 0.15% 177

Other funds holding BLUE

Schonfeld Strategic Advisors's BLUE Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 5,498 shares — an estimated $152K sold.

Schonfeld Strategic Advisors first reported a position in BLUE in Q1 2016 and held it in 13 quarters. The position peaked at $2.04M in Q2 2018. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 5,498 bluebird bio shares in Q1 2024, an estimated $152K.
  • Schonfeld Strategic Advisors first reported a position in bluebird bio in Q1 2016 and held it in 13 quarters.
  • Schonfeld Strategic Advisors's bluebird bio position peaked at $2.04M in Q2 2018.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.